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Background: Healthcare-associated infections (HAIs) are a frequent complication associated with hospitalization of
infants in neonatal intensive care units (NICUs). The aim of this study was to evaluate and describe the results of
surveillance of HAIs in a III level NICU in Naples, Italy during 2006–2010.
Methods: The surveillance covered 1,699 neonates of all birth weight (BW) classes with > 2 days NICU stay.
Infections were defined using standard Centers for Disease Control and Prevention definitions adapted to neonatal
pathology and were considered to be healthcare-associated if they developed > 2 days after NICU admission.
Results: One hundred-fifty-three HAIs were diagnosed with a frequency of 9% and an incidence density of 3.5 per
1000 days of hospital stay. HAIs developed in all BW classes, but patients weighing ≤ 1000 g at birth were more
affected with a decreasing trend from the lowest to the highest BW classes. Sepsis proved to be the most frequent
infection (44.4%), followed by urinary tract infection (UTI) (28.8%), pneumonia (25.5%) and meningitis (1.3%). Device
associated infections (i.e. central line-associated bloodstream infections (BSIs), umbilical catheter-associated BSI and
ventilator associated pneumonias (VAPs) represented 64.1% of all HAIs. Most frequent pathogens responsible for all
types of infections were: P. aeruginosa (17%), C. parapsilosis (16.3%), E. coli (13.1%), C. albicans (10.5%), non- extended
spectrum beta-lactamase (ESBL) K. pneumoniae (7.8%), and coagulase-negative Staphylococci (5.2%). No microbiological
diagnosis was achieved for 6.5% of infections.
Conclusions: HAIs developed in all BW classes but low BW neonates were at major risk to acquire HAIs in our NICU.
Use of central line-, umbilical-catheter and mechanical ventilation was associated with higher risk of infection. Our
findings highlight the importance of an extensive surveillance approach in the NICU setting, which includes all BW
classes of neonates and monitors infections associated with the use of medical devices.
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Healthcare-associated infections (HAIs) are frequent and
critical complications associated with hospitalization of
neonates, especially very low birth weight (VLBW) neo-
nates, in neonatal intensive care units (NICUs) [1,2]. Ac-
tive surveillance systems for HAIs in NICUs have been
developed in USA and Canada by the National Healthcare* Correspondence: rafzarri@unina.it
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unless otherwise stated.Safety Network (NHSN) [3,4], the Vermont Oxford
Network [5,6] and the Canadian Neonatal Network [7]. In
Europe, surveillance systems for HAIs in NICUs are active
in Germany [8,9] and in England [10].
The first national report on HAIs in Italian intensive
care units (ICUs) has recently been published [11]. The
document shows the results of HAIs surveillance activities
for the 2009–2010 period and mainly focuses on adult
ICUs, with a very limited contribution of pediatric ICUs
and none of NICUs.
While several studies have shown the spread of spe-
cific nosocomial pathogens, such as ESBL producing. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[14], methicillin resistant Staphylococcus aureus [15], ex-
tensively drug resistant (XDR) Acinetobacter baumannii
[16], Candida parapsilosis [17] in Italian NICUs, few
studies were performed on the prevalence [18] or inci-
dence of HAIs in NICUs [19-21]. Active surveillance of
HAIs was utilized in the majority of the studies from
Italian NICUs [12-16,18,21].
Objective of the present study was to describe and dis-
cuss the results of surveillance of HAIs in a neonatal in-




The University of Naples “Federico II” NICU is a III level
NICU with a total of 25 incubators and cradles. The ward
serves the University Obstetric Clinic (approximately 2000
births/year) which is both a high risk pregnancy center
and an obstetric emergency service. Moreover, the NICU
admits outborn neonates from the regional Newborn
Emergency Transport Service.
Active surveillance
Healthcare-associated infections (HAIs) active, patient-
based surveillance (AS) is continuously carried out by
trained personnel. Data are collected on weekly basis dir-
ectly from patient’s charts. Any clinical issues are directly
discussed with caregivers. Data are analyzed on monthly
basis and expressed as monthly report. Monthly report
consist of patient data, data on swab isolations of sentinel
pathogens, device utilization ratios and infection data. All
neonates with > 2 days NICU stay enter the AS system
and data regarding birth (birth weight (BW), gestational
age, type of delivery, and Apgar score), invasive device ex-
posure (days of umbilical and central line catheterization
and of invasive ventilation), antimicrobial therapy expos-
ure (yes/no) and infections are collected. End of surveil-
lance coincides with neonates’ discharge from the ward.
Infections are defined using standard Centers for Disease
Control and Prevention definitions adapted to neonatal
pathology [22-24] and are considered to be healthcare-
associated if they develop > 2 days after NICU admission.
We exclude neonates with a vertical infection (ie, an infec-
tion transmitted from mother to child) or infection ac-
quired during delivery. This paper analyzes data from the
HAIs AS system over a 5 years long period (2006–2010).
For this study purposes, only sepsis, meningitis, pneumo-
nia, and urinary tract infections (UTIs) were considered.
Central line-associated blood-stream infections (BSI), um-
bilical catheter-associated BSI and ventilator-associated
pneumonia (VAP) were attributed if a central line, an um-
bilical catheter and invasive ventilation, respectively, were
in place at the time of or within 48 hours before infectiononset [24]. Frequency measures were calculated as percent
of infection and as incidence densities, i.e. infection rates
per 1000 days of hospital stay or 1000 days of directly
related invasive device within 5 BW classes (≤750 g,
751–1000 g, 1001–1500 g, 1501–2500 g, and ≥ 2501 g).
Device utilization rates within such classes were also cal-
culated. The etiology of all infections within each birth-
weight class was assessed during the study period.
HAIs surveillance is regulated by the Regional Health
Authority and it is one of the basic components of the
Regional Plan for Healthcare-associated infections Preven-
tion and Control [25]. The HAIs AS system manages data
in a cumulative form with the ultimate goal of diseases’
surveillance in the population and continuous improve-
ment of quality in healthcare. Results of surveillance activ-
ities are periodically reported to the Regional Health
Authority. As such, no patient informed consent, nor local
Ethical Committee authorization is required.
Statistical analysis
Data were analysed using SPSS 11.0 (Chicago, IL, USA).
Finally, ANOVA or Kruskal Wallis test were used as ap-
propriate to assess significant differences (p < 0.05) in
the above-mentioned variables over the five-years study
period. Linear regression analysis was performed to de-
tect significant time-dependent and BW-related trends
as previously described [26,27].
Results
Between years 2006 and 2010 1699 neonates, correspond-
ing to 91.49% of all admissions to the ward, entered the
HAIs AS system and a total of 43447 patient days were
registered. The remaining 8.51% of admissions was ex-
cluded because either ineligible (length of stay < 2 days) or
missed by the HAIs AS system. During the study period
neonates with > 1000 g BW accounted for 74% of total pa-
tient days (1001–1500 g, 1501–2500 g, and ≥ 2501 g clas-
ses representing 26.7%, 28.1%, and 19.2%, respectively)
while the remaining 26% was distributed among extremely
low BW (ELBW) infants (≤750 g and 751–1000 g BW
classes accounting for 9.1% and 16.9% of total patient
days, respectively). Statistically significant differences in
length of hospitalization over the five-years period were
detected in the lower BW classes (p = 0.003, 0.047, and
0.004 for ≤ 750 g, 751–1000 g, and 1001–1500 g classes,
respectively), and total patient days in the ≤ 750 g BW
class showed a statistically significant decreasing trend
over time (R2 = 0.228, p = 0.000) (Table 1).
Percentiles of device utilization rates in the five BW
classes are shown in Table 2. No statistically significant
differences within each BW class were found over the five
years study period for devices utilization rates, except
for mechanical ventilation in the 751–1000 g and 1001–
1500 g BW classes (p = 0.000 and 0.002, respectively). The
Table 1 Neonates data per birthweight category during the study period
Year 2006 2007 2008 2009 2010 Total
Hospitalized patients 339 392 395 427 304 1857
Surveilled patients 310 357 357 384 291 1699
Number of patient days* 8020 9012 9259 8361 8795 43447
≤ 750 g 1127 890 903 475 564 3959
751-1000 g 1939 1194 1400 1055 1773 7361
1001-1500 g 1628 2748 2927 2258 2038 11599
1501-2500 g 2084 2585 2292 2731 2500 12192
>2500 g 1242 1595 1737 1842 1920 8336
Number of umbilical catheter days* 729 803 775 924 1001 4232
≤750 g 92 94 80 124 112 502
751-1000 g 180 74 106 88 217 665
1001-1500 g 191 280 265 259 267 1262
1501-2500 g 173 182 166 267 254 1042
>2500 g 93 173 158 186 151 761
Number of central line days* 1044 1049 1374 1133 1395 5995
≤750 g 213 194 214 125 145 891
751-1000 g 430 213 268 187 370 1468
1001-1500 g 187 263 439 396 402 1687
1501-2500 g 158 229 271 287 331 1276
>2500 g 179 150 182 138 147 796
Number of ventilator days* 1044 843 1075 702 1544 5208
≤750 g 298 286 362 149 258 1353
751-1000 g 492 245 214 77 604 1632
1001-1500 g 142 97 257 115 334 945
1501-2500 g 70 142 156 196 208 772
>2500 g 42 73 86 165 140 506
*Data refer to surveilled patients.
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(R2 = 0.091, p = 0.020).
The overall number of HAIs registered during the study
period by the local AS system was 153 (9% total infection
rate and 3.5 total incidence density per 1000 days of hos-
pital stay). HAIs developed in all BW classes, but patients
weighing ≤ 1000 g at birth were more affected (45.8% of
all HAIs) and a statistically significant decreasing trend
(R2 = 0.964, p = 0.003) from the lowest to the highest BW
classes in terms of incidence density per 1000 days of
hospital stay was observed (7.83, 5.298, 3.104, 2.297, and
2.279 in ≤ 750 g, 751–1000 g, 1001–1500 g, 1501–2500 g,
and ≥ 2501 g BW newborns, respectively). On the whole,
sepsis proved to be the most frequent infection (44.4%),
followed by UTIs (28.8%), pneumonia (25.5%) and menin-
gitis (1.3%). Device associated infections (i.e. central line-
associated BSI, umbilical catheter-associated BSI and
VAPs) represented 64.1% of all HAIs. Incidence densities
of device-associated infections among the five BW classes
are shown in Table 3. Incidence densities of the threetypes of device associated infections showed no statisti-
cally significant differences within each BW class over the
five years study period, and within the five years of the
study period when related to the five BW classes, with the
exception of ventilator-associated pneumonia (VAP)
in year 2008, which showed a statistically significant, de-
creasing trend from the lowest to the highest BW classes
(R2 = 0.130, p = 0.005).
Etiology of device-associated infections among the
five BW classes are shown in Table 4. Most frequent
pathogens responsible for all types of infections were:
P. aeruginosa (17%), C. parapsilosis (16.3%), E. coli
(13.1%), C. albicans (10.5%), non-ESBL K. pneumoniae
(7.8%), and coagulase-negative Staphylococci (5.2%). The
remaining 23.5% of infections were caused by either En-
terobacteriaceae, Candida species, S. aureus or other
gram-positive cocci, each accounting for less than 5% of
all infections. No statistically significant differences during
the five-years period were detected among such patho-
gens. Moreover, for 6.5% of infections no microbiological
Table 2 Percentiles of the distribution of device
utilization rates in surveilled neonates during the study
period
10° 25° 50° 75° 90°
Umbilical catheter utilization rate
≤750 g .000 .021 .105 .191 .447
751-1000 g .000 .029 .075 .125 .169
1001-1500 g .052 .058 .105 .142 .178
1501-2500 g .021 .049 .080 .117 .149
>2500 g .017 .041 .081 .135 .167
Central catheter utilization rate
≤750 g .000 .038 .164 .395 .563
751-1000 g .000 .085 .159 .302 .380
1001-1500 g .017 .066 .140 .200 .277
1501-2500 g .000 .030 .103 .161 .213
>2500 g .000 .037 .074 .139 .221
Mechanical ventilation utilization rate
≤750 g .000 .117 .352 .564 .748
751-1000 g .000 .059 .175 .329 .500
1001-1500 g .005 .015 .035 .131 .190
1501-2500 g .006 .020 .051 .102 .152
>2500 g .000 .014 .039 .101 .137
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significant differences during the five-years period
(p = 0.024) and a statistically significant decreasing trend
over the studied interval (R2 = 0.116, p = 0.008).
The most frequent device-unrelated HAIs were UTIs
(77.2% of all), which mainly affected neonates belonging
to the 1001–1500 g and 1501–2500 g BW classes
(distribution of UTIs was 0%, 9,1%, 45.5%, 31.8% and
13,6% in ≤ 750 g, 751–1000 g, 1001–1500 g, 1501–2500 g,
and ≥ 2501 g BW newborns, respectively). UTIs incidence
density per 1000 days of hospital stay showed no statisti-
cally significant differences within each BW class over the
five years study period, and within the five years of
the study period when related to the five BW classes, with
the exception of year 2008, which showed a statistically
significant increasing trend from the lowest to the highest
BW classes (R2 = 0.812, p = 0.037).
Twenty-five percent of UTIs were caused by E. coli,
followed by K. pneumoniae (18.2%, half of which displayed
ESBL phenotype), Candida spp. (15.9%), P. aeruginosaTable 3 Incidence densities of device-associated infections pe
Device-associated infection ≤75
Umbilical catheter associated bloodstream infection (pooled mean)* 6.12
Central catheter associated bloodstream infection (pooled mean)* 11.6
VAP (pooled mean)* 9.93
*Data refer to cases per 1000 specific device-days.(13,6%), Enterobacter spp. and Enterococcus spp.
(6.8% each); the remaining 13.7% included ESBL-producing
Klebsiella oxytoca and Serratia marcescens, Proteus mir-
abilis, polimicrobial and undetermined aetiologies.
One half of catheter-unrelated sepsis was not sup-
ported by microbiological identification and one half
was caused by C. albicans, E. faecalis, P. aeruginosa, and
Streptococcus viridans. Pathogens responsible for the 3
ventilator-unassociated pneumonias were S. epidermidis,
E. coli and K. pneumoniae. In one case, meningitis
evolved from a C. albicans umbilical catheter-associated
BSI in a ≤ 750 g BW neonate, in the other no aetiology
was defined (Table 4).
Discussion
Surveillance is a well-established prevention measure of
healthcare-associated infections (HAIs) and reductions in
HAIs rates are to be expected on the medium to long
term period at those institutions which systematically
carry out such activities [23,28,29]. HAIs AS in the Uni-
versity of Naples “Federico II” NICU was started in the
mid 1990s and has been going on since then according to
the Atlanta’s CDC methodology (National Nosocomial In-
fections Surveillance System NNIS before and NHSN
nowadays) [22-24]. Data here described show that during
the 2006–2010 period no significant change in HAIs rates
took place. Nevertheless, when compared to previous data
referred to the same NICU over a 54-months period be-
tween years 1996 and 2000 [12], our findings demonstrate
that HAIs rates, in terms of both total infection rate and
total incidence density per 1000 days of hospital stay, were
reduced by nearly half in a fourteen years time span
(9% and 3.5 vs. 17.2% and 7.3). Further analysis of factors
which, other than HAIs AS, led to such variations goes be-
yond the scope of this research.
Moreover, during the study period here described, two
outbreaks [14,16] took place in the ward and this may par-
tially explain the absence of statistically significant changes
in all HAIs rates. On the other hand, during one of such
outbreaks [14], an intense educational programme on
hand hygiene was carried out in the ward and its positive
effects may have improved infection rates.
The HAIs AS system here adopted is basically inspired
to Centers for Disease Control and Prevention (CDC)’s
NHSN - device associated module, thus benchmarking of
our data against infection rates of NHSN reports appearsr birth weight category in surveilled neonates
0 g 751-1000 g 1001-1500 g 1501-2500 g >2500 g
7 0.331 1.231 0.892 1.695
36 8.644 4.731 4.544 6.981
6.896 1.346 1.577 5.595
Table 4 Etiology of device-associated infections per birth weight category in surveilled neonates
Umbilical catheter associated bloodstream infection ≤750 g 751-1000 g 1001-1500 g 1501-2500 g >2500 g Total (%)
Candida parapsilosis 3 1 2 0 0 6 (50)
Escherichia coli 0 0 0 2 1 3 (25)
Candida albicans 1 0 0 0 1 2(16.7)
CONS 0 1 0 0 0 1 (8.3)
Total (% within BW category) 4 (33.3) 2 (16.7) 2 (16.7) 2 (16.7) 2 (16.7) 12 (100)
Central catheter associated bloodstream infection ≤750 g 751-1000 g 1001-1500 g 1501-2500 g >2500 g Total (%)
Candida parapsilosis 3 4 5 2 3 17 (35.4)
Candida albicans 1 3 0 2 1 7 (14.6)
Escherichia coli 0 4 0 0 0 4 (8.3)
Pseudomonas aeruginosa 3 1 0 0 0 4 (8.3)
Klebsiella pneumoniae ESBL+ 0 0 1 2 0 3 (6.3)
Serratia marcescens 2 1 0 0 0 3 (6.3)
CONS 0 0 2 0 0 2 (4.2)
Candida glabrata 0 0 1 0 0 1 (2.1)
Enterobacter spp. 0 1 0 0 0 1 (2.1)
Enterococcus faecalis 0 0 1 0 0 1 (2.1)
Not determined 0 0 1 0 0 1 (2.1)
polimicrobial (Candida albicans + Pseudomonas aeruginosa) 1 0 0 0 0 1 (2.1)
Rothia mucillaginosa 0 0 0 0 1 1 (2.1)
Staphylococcus aureus 0 0 0 1 0 1 (2.1)
Streptococcus spp. 1 0 0 0 0 1 (2.1)
Total (% within BW category) 11 (22.9) 14 (29.2) 11 (22.9) 7 (14.6) 5 (10.4) 48 (100)
VAP ≤750 g 751-1000 g 1001-1500 g 1501-2500 g >2500 g Total (%)
Pseudomonas aeruginosa 5 7 0 1 2 15 (41.7)
Acinetobacter baumannii 2 1 1 0 0 4 (11.1)
CONS 0 2 1 0 1 4 (11.1)
Klebsiella pneumoniae ESBL+ 1 2 1 0 0 4 (11.1)
Candida albicans 1 1 0 0 0 2 (5.6)
Escherichia coli 1 1 0 0 0 2 (5.6)
Not determined 1 0 0 1 0 2 (5.6)
Polimicrobial (K. pneumoniae ESBL+ + P. aeruginosa) 0 0 0 1 0 1 (2.8)
Staphylococcus aureus 0 1 0 0 0 1 (2.8)
Stenotrophomonas maltophilia 0 1 0 0 0 1 (2.8)
Total (% within BW category) 11 (30.6) 16 (44.4) 3 (8.3) 3 (8.3) 3 (8.3) 36 (100)
Abbreviations: NICU, neonatal intensive care unit; CONS, coagulase negative staphylococci; ESBL+, extended spectrum beta-lactamase producer; VAP,
ventilator-associated pneumonia.
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data reports referred to the 2006–2009 period were con-
sidered, while the one referred to year 2010 was excluded
because starting from that year bloodstream infections
returned to be related to central lines in general, with no
distinction between umbilical and central catheters
[3,4,30].
Pooled mean infection rates at our institution proved to
be higher than those reported by NHSN, yet always lowerthan the 90° value for the middle BW classes (751–1000 g,
1001–1500 g, and 1501–2500 g). On the contrary, extreme
BW classes (≤750 g and ≥ 2501 g) infection rates con-
stantly performed as high outliers. Such results are not in
contrast with the strong, BW-related decreasing trend
(R2 = 0.964, p = 0.003) we observed from the lowest to the
highest BW classes, since it refers to the overall infection
incidence density per 1000 days of hospital stay and not
only to device-associated infections. Moreover, with the
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BW neonates, our percentile distributions of devices’
utilization rates show lower values than those of NHSN.
These findings suggest that specific problems may exist in
the ≤ 750 g and ≥ 2501 g BW classes, but they also point
out that comparisons between very diverse healthcare
systems may be confounding or not appropriate because
of objective differences in clinical practice and standards
of care.
A well-established European neonatal surveillance net-
work is Germany’s Neonatal-Krankenhaus Infektions Sur-
veillance System (NEO-KISS). Unlike the NHSN
surveillance system, the NEO-KISS system monitors HAI
occurring in all very low birth weight (VLBW) infants
(BW < 1500 g) in NICUs until discharge, until death, or
until they reach 1800 g. The system identifies different
BW classes (≤499 g, 500–999 g, 1000–1499 g) and makes
no distinction between umbilical and central line [8,9].
Thus, a possible comparison between our data and the
latest NEO-KISS report [31] can only be made for VAP
rates in the 1000–1500 BW class, which appear to be
similar (1,34 and 1,17 at our NICU and in NEO-KISS,
respectively).
A more pertinent benchmarking would be on a national
scale. As previously pointed out, though, no data from
NICUs is included in the first national report on HAIs in
Italian ICUs. A multicentre prospective cohort study in six
Italian NICUs lasting 28 months described a 12.8% infec-
tion rate, with an incidence density of 6.93 episodes per
1,000 patient days [21]. A three years surveillance report
from a single NICU showed similar results: 13.2% infec-
tion rate with an incidence density of 7.8 episodes per
1,000 patient days [20]. Our data appear to be consider-
ably lower but, again, questions on the accuracy of
national-based, yet network-unrelated comparisons arise.
The present study shows that over time a substantial
change in HAIs etiology at our NICU has taken place: in
the previous decade the most commonly isolated micro-
organism was Staphylococcus epidermidis, which caused
28% of all HAIs [12]. During the 2006–2010 period,
most frequent pathogens were gram-negative bacteria
(P. aeruginosa, E. coli, K. pneumoniae) and fungi (C. para-
psilosis, C. albicans), while coagulase-negative Staphylo-
cocci dropped down to 5.2%. Such trend proved to be
stable over time (no statistically significant differences dur-
ing the five-years period were detected among such patho-
gens) and quite well reproducible in all specific types of
HAIs (umbilical and central catheter-associated BSIs,
VAPs and UTIs). Moreover, it is worth-mentioning
that BSIs at our institution were mainly caused by
C. albicans and C. parapsilosis. Fluconazole prophylaxis
for neonates ≤1500 g BW was introduced during 2009 at
our NICU. These findings partially agree with a previous
prospective surveillance study on nosocomial infections insix NICUs in Brazil which showed that Gram-negative rods
(mainly Klebsiella sp. and E. coli) were responsible for
51.6% episodes of BSI, Gram-positive organisms and
Candida sp. accounted for 37.4 and 11.1%, respectively [32].
On the other hand, our data strongly differ from two recent
NICU long period-based reports describing a prevalent
gram-positive etiology for BSI [33,34]. These discrepancies
may depend on differences in the clinical settings.
Our data also showed that 48/60 (80%) BSI were associ-
ated with central-line catheter use, 12/60 (20%) with um-
bilical catheter. Although data collection is more
complicated, we speculate that the separation between
umbilical and percutaneous catheters-associated BSIs is
worth maintaining in order to better identify problems
and prevention strategies.
Interestingly, clinical sepsis (i.e. not determined eti-
ology) significantly decreased during the study period.
This should imply less broad spectrum molecules use
and targeted antimicrobial prescription, however such
variables are not examined in this paper and the consid-
ered time interval is probably too short to show varia-
tions in bacterial resistance phenotypes.
Most reports on HAIs in NICUs focus on BSIs and,
eventually, on VAPs. Our data shows that the most fre-
quent infection after BSIs is UTI. Although UTI were di-
agnosed according to validated criteria [4], no sterile
urine collection through supraumbilical aspiration was
performed. In agreement with our data, a previous sur-
veillance study of HAI in an Italian NICU reported that
UTI are the third most frequent cause of infection after
BSI and pneumonia [20].
Finally, the data reported herein show that HAIs devel-
oped in all BW classes. Although a decreasing trend from
the lowest to the highest BW classes in terms of incidence
density per 1000 days of hospital stay was observed,
all device-associated infection rates in ≥ 2501 g BW neo-
nates proved to be higher than those recorded in the
1000–2500 g BW classes. This is in agreement with other
surveillance studies in European NICUs which have also
described infectious complications in the upper BW
classes [10,20,21,33]. Moreover, this finding underlines the
importance of HAIs surveillance in NICUs for all BW
classes newborns.
Conclusions
In our NICU, all BW classes were affected by HAIs, but
low birth weight neonates were at major risk to acquire
HAIs. Sepsis, UTI and pneumonia were the most frequent
infection in our NICU. Because use of central line-,
umbilical-catheter and mechanical ventilation was associ-
ated with higher risk of HAI in our clinical setting, a
surveillance protocol which monitors device-associated in-
fections in all BW classes neonates may represent a useful
tool to prevent HAIs in the NICU. The absence of
Crivaro et al. BMC Infectious Diseases  (2015) 15:152 Page 7 of 8national, network-based data in the NICU context impairs
benchmarking activities and, thus, may limit surveillance
systems’ contribution to HAIs prevention.
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